FidaxoMicin powder
CAS NO.: 873857-62-6
Molecular formula:C52H74Cl2O18
Synonyms:Dificid, Dificlir, Difimicin
Purity : 98% HPLC
Certificate:COA; HPLC; MSDS; TDS,etc.
MOQ : 10g ,100g
Shipping: DHL/FedEx/UPS/USPS Safe and fast delivery
Lead Time: 1-3 days
Warehouse: USA and Germany warehouse
- Product Description
Xi'an Faithful BioTech Co., Ltd: Your Trusted FidaxoMicin powder Manufacturer & Supplier
Xi'an Faithful BioTech Co., Ltd. focuses on the research and production of FidaxoMicin powder, and always regards excellent quality as the foundation. We provide accurate and reliable products and services to customers all over the world through flexible and customizable product solutions. We always provide solid assistance for the development of every customer with professionalism and responsibility.
FidaxoMicin powder Introduction
Fidaxomicin Powder is a macrolide antibiotic. It is a white to off-white powder, semi-synthesized by fermentation of the actinomycete Actinoplanes deccanensis, and is a first-in-class narrow-spectrum antibacterial drug. Its mechanism of action is to inhibit the σ subunit of bacterial RNA polymerase, thereby blocking transcription initiation. The active pharmaceutical ingredient is almost entirely not absorbed by the intestines after oral administration, exerting its bactericidal effect locally.
Specifications
Item | Specifications | Results |
Appearance | White to Light yellow powder to crystal | conforms |
purity | ≥95% (HPLC) - ≥99.93% | conforms |
Water Content | ≤0.5% | conforms |
Melting Point | >160°C | conforms |
Conclusion | Complies with enterprise standard | |
Application area
Fidaxomicin is primarily used in pharmaceutical manufacturing, specifically for the following purposes:
- Treatment of Clostridium difficile infection-associated diarrhea: As the active ingredient in Dificid, a prescription drug approved by the FDA and NMPA, it is used to treat Clostridium difficile infection-associated diarrhea in adults and children over 6 months of age, with a standard treatment course of 10 days.
- Treatment to reduce infection recurrence: Clinical studies have shown that Fidaxomicin significantly reduces the recurrence rate of infection compared to traditional vancomycin treatment due to its less disruptive effect on the normal intestinal flora.
- Anti-infective therapy in immunocompromised individuals: Used for the treatment of Clostridium difficile opportunistic infections in immunocompromised individuals, such as those infected with HIV.
- Development of oral suspension formulations: The active pharmaceutical ingredient can be used to prepare oral suspension formulations suitable for patients with dysphagia.
Main Advantages of Fidaxomicin Powder
First-of-its-kind mechanism of action: As an inhibitor of the σ subunit of RNA polymerase, it blocks bacterial RNA synthesis at the transcription initiation stage, exhibiting no cross-resistance with traditional antibiotics.
- Targeted bactericidal action, protecting the gut microbiota: Its narrow-spectrum antibacterial properties kill only specific pathogens such as Clostridium difficile, with minimal impact on normal gut microbiota, thus significantly reducing the risk of relapse.
- Practically no systemic absorption, high safety: Systemic absorption after oral administration is extremely low. Clinical trials show that the incidence of serum transaminase elevation is only 1%-3.2%, with no reports of clinically significant liver injury.
- Fixed dosage, convenient use: The standard adult dose is 200 mg twice daily for 10 days, with good patient compliance.
If you need it ,you can click here
Why choose us
The strict quality gatekeeper: We are intermediaries, but also quality inspectors. Each batch of Adonitol raw powder is ensured to have a content of ≥ 99% and no risk of excessive plasticizers or heavy metals before being stored.
Flexible distribution and warehousing. There is no minimum order quantity (MOQ) pressure directly supplied by the factory. We support trial production of 1kg samples and also support full box shipment.
Quality Control

R&D Results

Packaging and Transportation


After-Sales Service

Qualification Certification

Exhibition

FAQ
Q1: Can the quality of Fidaxomicin powder meet the requirements for antibacterial research and development?
A1: The purity of Fidaxomicin powder is stable and meets standards. Impurities and residual solvents are strictly controlled. Each batch is equipped with a Certificate of Analysis (COA) and test report. Its antibacterial activity is stable, with strong batch-to-batch consistency, fully meeting the needs of antibacterial experiments and formulation development.
Q2: The batch variation of this antibacterial raw material is small. Can it guarantee stable experimental data?
A2: The raw material production process is mature, the powder is uniform and fine, the content of active ingredients is constant, the antibacterial effect is balanced and controllable, and the batch error is minimal. This effectively avoids data deviations caused by raw material factors, ensuring the smooth progress of the project.
Q3: Can the supply and delivery of Fidaxomicin powder be stable in the long term?
A3: We have long-term lock-in with the original manufacturer's production capacity, maintain sufficient stock, support orders of all sizes, offer fast delivery, and implement compliant quality control throughout the process. Long-term supply is worry-free and suitable for small-scale, pilot-scale, and mass production procurement needs.
Contact US
Contact us allen@faithful bio.com. Choosing us means make the supply chain more efficient and get hight quality FidaxoMicin powder.




